SLN

Silence Therapeutics PLC

Price

$19.80

return (12m)

204.15%

p/e

-46.78

p/bv

72.90

DIVIDEND YIELD

0.00%

SLN price

Silence Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment SLN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

115.92%

3 months

66.53%

1 year

204.15%

2 years

11.05%

5 years

-13.91%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals SLN

Valuation

P/E

-46.78

Sector -3.16

Industry -3.16

P/BV

72.90

Sector 1.80

Industry 1.80

P/Revenue (PSR)

4,560.06

Sector 2.04

Industry 2.04

EV/EBITDA

-46.06

Sector -204.34

Industry -204.34

EV/EBIT

-45.69

Sector -42.58

Industry -42.58

P/EBITDA

-47.28

Sector -19.73

Industry -19.73

P/EBIT

-46.90

Sector -67.09

Industry -67.09

P/Total Assets

26.35

Sector 1.06

Industry 1.06

P/Net Current Assets

106.47

Sector -9.56

Industry -9.56

P/Working Capital

34.38

Sector -93.82

Industry -93.82

EPS

-0.42

Sector -1.78

Industry -1.78

BVPS

0.27

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

85.85%

Sector 41.28%

Industry 41.28%

EBITDA Margin

Sector -21,198.78%

Industry -21,198.78%

EBIT Margin

-100.00%

Sector -35.28%

Industry -35.28%

Net Profit Margins

-100.00%

Sector -35.71%

Industry -35.71%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-90.41%

Sector -61.32%

Industry -61.32%

ROA

-44.14%

Sector -54.29%

Industry -54.29%

ROIC

-185.89%

Sector -1,801.33%

Industry -1,801.33%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

7.42

Sector 2.91

Industry 2.91

Net Debt / EBITDA

1.21

Sector -20.38

Industry -20.38

Net Debt / EBIT

1.20

Sector -4.13

Industry -4.13

Net Debt / Equity

-1.87

Sector -33,112.98

Industry -33,112.98

Gross Debt / Equity

0.00

Sector -0.64

Industry -0.64

Equity/Assets

0.36

Sector 0.46

Industry 0.46

Liabilities/Assets

0.64

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

-48.50%

Sector -

Industry -

5Y Earnings CAGR

2.14%

Sector -

Industry -

Fundamentals SLN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SLN Silence Therapeutics PLC	$19.80	199.55%	0.00%	-46.78	72.90	-90.41%	-100.00%
PFE Pfizer Inc.	$30.79	37.60%	5.73%	39.46	2.00	4.97%	6.80%
ABBV AbbVie Inc.	$294.83	40.92%	2.31%	53.66	0.00	-%	14.76%
NVO Novo Nordisk A/S	$42.18	-8.62%	4.66%	9.73	5.17	60.28%	35.32%
MRK Merck & Co. Inc.	$150.36	87.62%	2.27%	116.34	8.79	6.97%	4.77%
AZN AstraZeneca PLC	$189.01	18.47%	1.73%	22.38	5.77	27.27%	16.95%
BMY Bristol-Myers Squibb Company	$64.19	45.68%	5.06%	13.78	5.44	44.06%	18.47%
ZTS Zoetis Inc.	$89.20	-37.02%	2.60%	12.71	10.64	64.91%	27.69%
AMGN Amgen Inc.	$478.48	66.83%	2.13%	28.86	21.58	91.47%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$930.67	45.04%	0.41%	21.68	2.96	14.04%	27.86%
HALO Halozyme Therapeutics Inc.	$130.34	96.89%	0.00%	37.10	106.90	173.67%	24.86%
MCK McKesson Corporation	$1,069.44	31.01%	0.34%	25.96	-30.85	-168.45%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$549.04	28.88%	0.00%	32.22	7.01	23.54%	35.00%
CAH Cardinal Health Inc.	$261.93	39.00%	0.81%	34.74	-21.86	-63.98%	0.67%
ARGX argenx SE	$931.38	12.72%	0.00%	13.26	-	-%	25.42%
HRMY Harmony Biosciences Holdings Inc.	$34.42	17.34%	0.00%	12.39	2.25	20.46%	18.88%
BIIB Biogen Inc.	$254.46	68.03%	0.00%	45.08	2.00	4.58%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SLN - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Silence Therapeutics

Silence Therapeutics PLC

Average Investor10 user rating

4.0 (0 people)

United States

32 years

Founded: 1994

2020

Time since IPO - 6 years

74

Employees

Silence Therapeutics PLC (United States) is listed on the Nasdaq and has a market capitalization of $2.80 billion, with shareholders equity totaling $38.47 million.

The company employs approximately 74 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Silence Therapeutics PLC reported $615.00 Thousand in revenue, generating net income of $-59.95 million.

Key financial metrics include a P/E ratio of -46.78, a price-to-book (P/B) ratio of 72.90, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SLN.

Market cap

$2.80 billion

Net worth

$38.47 million

$38,471,000.00

Assets

$106.41 million

$106,412,000.00

Total Shares Outstanding

141.71 million

141,709,000

Average Daily Trading Volume

$2.85 million

$2,847,582.00

Sector

Health Care

Industry

Biotechnology

SLN

SLN revenue and profits

Financial Results SLN

DRAG THE FRAME TO SEE MORE DATA

SLN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$1,069.44 27,29% (12M)

P/E

25.96

0.34%

ROE

-168.45%

P/BV

-30.85

CAH - Cardinal Health

$261.93 34,36% (12M)

P/E

34.74

0.81%

ROE

-63.98%

P/BV

-21.86

ABBV - AbbVie

$294.83 40,35% (12M)

P/E

53.66

2.31%

ROE

P/BV

0.00

MRK - Merck & Co.

$150.36 83,40% (12M)

P/E

116.34

2.27%

ROE

6.97%

P/BV

8.79

AZN - AstraZeneca

$189.01 14,76% (12M)

P/E

22.38

1.73%

ROE

27.27%

P/BV

5.77

PFE - Pfizer

$30.79 35,87% (12M)

P/E

39.46

5.73%

ROE

4.97%

P/BV

2.00

BMY - Bristol-Myers Squibb

$64.19 44,27% (12M)

P/E

13.78

5.06%

ROE

44.06%

P/BV

5.44

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$1,069.44 27,29% (12 M)

P/L

25.96

0.34%

ROE

-168.45%

P/VP

-30.85

CAH - Cardinal Health

$261.93 34,36% (12 M)

P/L

34.74

0.81%

ROE

-63.98%

P/VP

-21.86

ABBV - AbbVie

$294.83 40,35% (12 M)

P/L

53.66

2.31%

ROE

P/VP

0.00

MRK - Merck & Co.

$150.36 83,40% (12 M)

P/L

116.34

2.27%

ROE

6.97%

P/VP

8.79

AZN - AstraZeneca

$189.01 14,76% (12 M)

P/L

22.38

1.73%

ROE

27.27%

P/VP

5.77

PFE - Pfizer

$30.79 35,87% (12 M)

P/L

39.46

5.73%

ROE

4.97%

P/VP

2.00

BMY - Bristol-Myers Squibb

$64.19 44,27% (12 M)

P/L

13.78

5.06%

ROE

44.06%

P/VP

5.44

Frequently Asked Questions

What is the price of Silence Therapeutics (SLN) today?

The current price of Silence Therapeutics (SLN) is $19.80. The stock began the year trading around $6.08 and is currently priced at $19.80. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Silence Therapeutics (SLN) pay dividends?

Silence Therapeutics (SLN) did not pay dividends over the past year.

Is Silence Therapeutics (SLN) a good investment?

Silence Therapeutics (SLN) is currently trading at $19.80 with a P/E ratio of -46.78. This represents a -1,730% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 204.15%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Silence Therapeutics (SLN) stock?

You can buy Silence Therapeutics (SLN) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol SLN and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Silence Therapeutics (SLN) yield today?

Over the past month, Silence Therapeutics (SLN) has returned 115.92% — 204.15% over the past year, and -13.91% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Silence Therapeutics (SLN) today at the current price of $19.80 your total investment would be $1,980.00.

Based on historical performance, the investment would have grown to approximately:

$6,022.17 after 1 year
$1,704.58 after 5 years
$1,980.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

SLN

Silence Therapeutics PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment SLN

Target price created!

Delete target price?

Your Target Price strategy deserves unlimited alerts

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING SLN WITH OTHER STOCKS

ABOUT Silence Therapeutics

Silence Therapeutics PLC

United States

32 years

2020

74

PROFIT X PRICE SLN

Financial Results SLN

SLN cash flow

Asset, Revenue and Profit Growth - SLN

SLN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions